Lugones meets Varsavsky over AI in healthcare: a political gesture with no deals or firm timelines

By Zendoric · October 9, 2026.

Argentina's Health Minister, Mario Lugones, met on October 9 with Martín Varsavsky to learn about Certuma, a company that develops artificial intelligence tools for clinical support. According to the minister's own account on his X account, the platform records and organizes information from consultations and assists doctors with clinical analysis, without replacing their professional judgment. The stated goal is to reduce doctors' administrative burden in order to free up time for patient care.

Varsavsky is a businessman known for a track record of more than two decades founding telecommunications companies (Jazztel, Ya.com, Fon) and, more recently, for his investments in reproductive health through Prelude Fertility. His presence alongside Certuma now places him in one of the segments of AI applied to medicine that has gained the most traction worldwide in recent years: so-called «clinical scribes» or ambient documentation systems, a category in which companies such as Abridge, Nuance (owned by Microsoft) or Suki already operate in the United States. In general, this type of tool tackles a very specific and well-documented problem: the time doctors spend writing up records instead of looking at the patient, identified as one of the main causes of professional burnout in primary care.

The striking thing about the story, however, is what it does not contain. The source article itself specifies that the official announcement does not detail whether there is any agreement, investment or implementation timetable for Certuma within Argentina's public health system. Lugones, moreover, framed the meeting within the economic discourse of Javier Milei's government, presenting it as proof that the country «is a place where technologies are developed» with international reach. In practice, it is more an act of public relations and political positioning than the announcement of a public policy: a meeting, a photo and a quote, with no visible contract or timetable.

That distinction matters. When a government publicly adopts a health technology without a transparent process of evaluation, procurement or tender, the initial enthusiasm may not translate into anything structural, or it may do so without the scrutiny that the handling of sensitive clinical data deserves. In the short term, the outstanding question is not whether AI can ease medical paperwork —there is ample evidence from other countries that it can— but under what rules of privacy, auditing and accountability such a tool would be introduced into Argentina's public health system. That gap in detail is, today, the real story behind the announcement.

In the long run, the substance of the matter does connect with a trend we consider irreversible: AI applied to everyday clinical practice —documenting, organizing, suggesting— is one of the most direct routes towards a medicine that devotes more human time to the patient and less to bureaucracy, a small but real step in the direction of more capable health systems and, over time, towards the more ambitious goal of preventing and treating diseases with greater precision. But that horizon is built with verifiable deployments, not with announcements that come without any fine print. For now, Argentina only has the photo.